English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03841110 /

FT500-101

FT500 As Monotherapy And In Combination With Immune Checkpoint Inhibitors In Subjects With Advanced Solid Tumors (Phase 1)

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: